What is Metastatic Cancer?

The term 'metastatic lymphoma' does not refer to a diagnosis. Unlike many of the subtypes of lymphoma we have featured in these articles, metastatic lymphoma is not one of them. While it is possible for a person's lymphoma to metastasize, or spread to distant sites of the body compared to where it began, it is not very common to discuss advanced lymphomas in terms of metastasis.

Metastatic Cancer Explained

When we discuss cancer, we normally do so according to anatomy breast cancer, lung cancer, kidney cancer, etc. If it is determined that, for example, a case of cancer began in the lungs, then the lungs would be considered the primary site of that cancer, meaning the site of the cancer's origin.

If it is later determined that the lung cancer is not merely confined to the lung, but has in fact spread to local sites (in this case, perhaps somewhere in the chest) as well as distant sites, then it would be considered a case of metastatic lung cancer.

While some metastatic cancers can be treated, most often when a cancer has metastasized well beyond its primary origin, it is not treatable and is often fatal. In fact, when we read of people dying from cancer, it is because their cancer has metastasized.

Metastatic Lymphoma

Simply because the term is not often used in lymphomas does not mean that lymphomas cannot metastasize. They can and often do spread to distant sites in the body if not controlled or caught early. However, when other cancers metastasize it normally means the cancer has formed a new secondary tumor in a new site. Since solid tumors aren't really an aspect of lymphoma and they are certainly not an aspect of leukemia, the notion of metastatic lymphoma becomes a little more complicated.

That said, on the rare occasion of metastatic lymphoma and that a lymphoma forms a distant tumor in the body, that tumor is most often found in the lungs, spleen, or the central nervous system.

Sources: Leukemia & Lymphoma Society, National Cancer Institute, National Institutes of Health
Photo: Pixabay

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap